BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38335272)

  • 1. Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion.
    Yan L; Wu M; Wang T; Yuan H; Zhang X; Zhang H; Li T; Pandey V; Han X; Lobie PE; Zhu T
    Cancer Res; 2024 Apr; 84(8):1270-1285. PubMed ID: 38335272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
    Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
    Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
    Chen M; Liu H; Hong B; Xiao Y; Qian Y
    FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Macrophage migration inhibitory factor is a vital player in Pan-Cancer by functioning as a M0 Macrophage biomarker.
    Pu Y; Yang G; Zhou Y; Pan X; Guo T; Chai X
    Int Immunopharmacol; 2024 Jun; 134():112198. PubMed ID: 38733827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.
    de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M
    Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
    Zhang M; Yan L; Kim JA
    Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
    Lv W; Chen N; Lin Y; Ma H; Ruan Y; Li Z; Li X; Pan X; Tian X
    Cancer Lett; 2016 Jun; 375(2):245-255. PubMed ID: 26952810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor involvement in breast cancer (Review).
    Richard V; Kindt N; Saussez S
    Int J Oncol; 2015 Nov; 47(5):1627-33. PubMed ID: 26412712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
    Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
    BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
    Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
    Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.
    Bando H; Matsumoto G; Bando M; Muta M; Ogawa T; Funata N; Nishihira J; Koike M; Toi M
    Jpn J Cancer Res; 2002 Apr; 93(4):389-96. PubMed ID: 11985788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation.
    Jia X; Xi J; Tian B; Zhang Y; Wang Z; Wang F; Li Z; Long J; Wang J; Fan GH; Li Q
    Cancer Immunol Res; 2024 Jan; 12(1):72-90. PubMed ID: 37956411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.